The SQUEEZE project will help with the optimization of existing treatments for Rheumatoid Arthritis (RA) by exploring the latest developments in the field of biomarkers. We are focusing on the effect and safety of medicines, and analyse the best implementation science to enhance the therapeutic relationship between patients and doctors.
Welcome to the SQUEEZE project
Rheumatoid arthritis (RA) is a chronic immune-mediated condition with enormous socioeconomic and individual impact. Despite the availability of various treatment options, every patient seems to respond differently. Furthermore, the unsuccessful choice of the most suitable medication for a particular patient can lead to a scenario in which the patient consumes a drug that doesn’t align with their body’s response, ultimately aggravating the patient’s condition. We, at SQUEEZE, in synergy with other EU-wide activities, work to validate clinical, laboratory, molecular, digital, and behavioural biomarkers to help tailor the best treatment to the individual patient. Our aim is to improve the efficacy, safety, and satisfaction with existing therapies (by squeezing the most out of them!).
15 PARTNERS
11 COUNTRIES
€ 12.5 Mio
5 years
OUR CONSORTIUM
We are a team of leading academic centres with a first-class record in translational and clinical research, patient research partners and small and medium sized enterprises (SME) active in the field of innovative digital healthcare products, science communication, and project management.
SQUEEZE project
We aim to have a real impact on the life of people with rheumatoid arthritis
LATEST NEWS
Bringing Rheumatology Research to the Public at Researchers’ Night Vienna
On 24 April, the SQUEEZE project joined hundreds of researchers, students, and science enthusiasts at the annual Researchers' Night in Vienna, hosted - amongst lots of other institutions - also by the Medical [...]
Synovial Biopsy: A Breakthrough in Rheumatoid Arthritis Care
A minimally invasive biopsy inside the joint is giving doctors new insight into rheumatoid arthritis — and bringing personalised treatment closer than ever. For millions of people living with rheumatoid arthritis, daily life [...]
Celebrating 30 Years of Academic Rheumatology in Austria
On 25 February 2026, the Division of Rheumatology at the Medical University of Vienna welcomed more than 120 guests to the historic Josephinum to celebrate a major milestone: 30 years of the Chair [...]
SQUEEZE on the road: Engaging Rheumatology Communities across Europe
Scientific exchange with the clinical community is a cornerstone of the SQUEEZE project. Over the past year, consortium members have actively participated in national and regional rheumatology congresses across Europe, bringing SQUEEZE research [...]
The SQUEEZE team at the EULAR PARE 2025 Conference: Advancing Meaningful Patient Involvement
In November 2025, the SQUEEZE consortium once again took part in the Annual European EULAR Conference of PARE (People with Arthritis / Rheumatism in Europe), reaffirming its strong commitment to meaningful and sustained [...]
